Corteva, Inc. $CTVA Holdings Increased by Schroder Investment Management Group

Schroder Investment Management Group increased its stake in Corteva, Inc. (NYSE:CTVA) by 7.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 522,286 shares of the company’s stock after acquiring an additional 37,681 shares during the period. Schroder Investment Management Group owned approximately 0.08% of Corteva worth $35,322,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in CTVA. Brighton Jones LLC raised its holdings in Corteva by 307.2% during the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after purchasing an additional 11,760 shares in the last quarter. Woodline Partners LP increased its position in shares of Corteva by 40.3% during the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after purchasing an additional 16,644 shares during the period. Savant Capital LLC raised its stake in shares of Corteva by 20.7% in the 2nd quarter. Savant Capital LLC now owns 20,711 shares of the company’s stock worth $1,544,000 after buying an additional 3,548 shares in the last quarter. Wedbush Securities Inc. raised its stake in shares of Corteva by 11.7% in the 2nd quarter. Wedbush Securities Inc. now owns 5,253 shares of the company’s stock worth $391,000 after buying an additional 549 shares in the last quarter. Finally, Fox Run Management L.L.C. bought a new stake in shares of Corteva in the 2nd quarter worth $238,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analyst Upgrades and Downgrades

CTVA has been the subject of several research reports. Deutsche Bank Aktiengesellschaft raised their target price on Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Jefferies Financial Group upped their price target on shares of Corteva from $85.00 to $95.00 and gave the company a “buy” rating in a report on Monday, March 2nd. Wells Fargo & Company raised their price objective on shares of Corteva from $77.00 to $85.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Zacks Research cut shares of Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. Finally, The Goldman Sachs Group reiterated a “buy” rating and issued a $88.00 target price on shares of Corteva in a report on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $82.90.

Insiders Place Their Bets

In related news, insider Brian Titus sold 8,311 shares of the stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This represents a 50.67% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.14% of the company’s stock.

Corteva Stock Up 3.1%

Shares of Corteva stock opened at $78.65 on Thursday. Corteva, Inc. has a 12-month low of $53.40 and a 12-month high of $80.90. The firm has a market capitalization of $52.89 billion, a PE ratio of 49.78, a price-to-earnings-growth ratio of 2.61 and a beta of 0.72. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The stock’s fifty day moving average is $73.63 and its 200-day moving average is $69.13.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22. The business had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.Corteva’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same quarter last year, the company posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s payout ratio is presently 45.57%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.